Steve Martin

Steve Martin has over 34 years experience in the ophthalmic pharmaceutical and medical device industry. He joined the board of QSpex Technologies in July 2008 and briefly served as QSpex’ Chief Business Office before taking on the CEO responsibility for QSpex in May 2009. Previously, Steve founded CIBA VISION Optics in 1980 and CIBA Vision Ophthalmics (now Novartis Ophthalmics) in 1990. He and his team grew sales of the combined companies to over $1.3 Billion with more than 6,000 employees. CIBA Vision is a world leader in research, development, manufacture and marketing of soft contact lenses, lens-care products and ophthalmic pharmaceuticals. Mr. Martin was President of CIBA Vision Corporation USA until 1998. Steve has personally successfully negotiated more than 70 licensing and acquisition deals with values ranging from $1 million to $320 million. He has assisted several start-ups in raising equity capital. He has served as a director on the boards of numerous public and private companies. Steve currently is a director of La Jolla Pharmaceutical Company (publicly traded), OcuCure Therapeutics (private), NeoVista, Inc. (private) and QSpex Technologies, Inc. (private). Steve is a graduate of Wake Forest University and attended the Woodrow Wilson College of Law. He holds 6 issued U.S. Patents for his inventions and a number of European patents. Steve was a Captain in the United States Marine Corps.